Fort Sheridan Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,694
Closed -$221K 290
2025
Q4
$221K Sell
2,694
-17
-0.6% -$1.32K 0.03% 251
2025
Q3
$204K Sell
2,711
-2,687
-50% -$200K 0.03% 262
2025
Q2
$400K Sell
5,398
-25
-0.5% -$1.74K 0.06% 181
2025
Q1
$438K Sell
5,423
-133
-2% -$11.4K 0.07% 166
2024
Q4
$434K Buy
5,556
+81
+1% +$6.88K 0.06% 172
2024
Q3
$514K Buy
5,475
+130
+2% +$10.9K 0.08% 148
2024
Q2
$416K Buy
5,345
+1,001
+23% +$81.6K 0.07% 168
2024
Q1
$395K Sell
4,344
-1,860
-30% -$155K 0.07% 150
2023
Q4
$480K Buy
6,204
+235
+4% +$16.5K 0.1% 130
2023
Q3
$406K Buy
+5,969
New +$434K 0.09% 125

Other funds holding GEHC

Fort Sheridan Advisors's GEHC Position: Q1 2026 in Review

Fort Sheridan Advisors sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 2,694 shares — an estimated $221K sold.

Fort Sheridan Advisors first reported a position in GEHC in Q3 2023 and held it in 10 quarters. The position peaked at $514K in Q3 2024. 1,272 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Fort Sheridan Advisors reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Fort Sheridan Advisors sold 2,694 GE HealthCare shares in Q1 2026, an estimated $221K.
  • Fort Sheridan Advisors first reported a position in GE HealthCare in Q3 2023 and held it in 10 quarters.
  • Fort Sheridan Advisors's GE HealthCare position peaked at $514K in Q3 2024.
  • 1,272 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Fort Sheridan Advisors's 13F filing for Q1 2026, filed 6 May 2026.